Assessing the Efficacy of Probiotics in Prevention of NEC in Preterm Babies

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeUp to 1
SponsorHayatabad Medical Complex

About this trial

The goal of the study is to check efficacy of probiotics in preventing necrotizing enterocolitis. The main questions would be if the preterm baby developed NEC or not.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Male and female preterm infants with a gestational age less than 35 weeks.

All indoor patients and outdoor patients who present within 24hrs of birth

Disqualifiers

• Infants with congenital or developmental gastrointestinal disorders for example omphalocele, malrotation, gastroschisis.

Infants with severe sepsis or gastrointestinal bleeding on presentation

Trial design

Design model

Parallel

Treatments tested in this trial

  • Probiotic

    Drug

    All preterm babies \<34 weeks Gestational age admitted within 24 hrs of life will be eligible for the study. Those full filling inclusion criteria and consenting to participate will be recruited. Consent will be obtained by team not caring for the patient. Each recruited patient will be assigned a case ID number. Based on the Randomization babies will be assigned to either the intervention group or control group. Study group: Multistrain probiotic containing a mix of Lactobacillus and Bifidobacterium spp. * Dose is 1 million international units (0.2ml or 5 drops) OD * Started as soon as feed is in initiated

  • 10% dextrose

    Drug

    This will receive 10% DW as placebo

Treatment groups

196 Participants
are divided into 2 treatment groups
Group A: Probiotic group - InterventionActive comparator 1 intervention
Group B: PlaceboPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Number of participants who develop NEC on probiotic vs placebo

Time frame
30 days

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: